Paydirt
CS
Insider

Christopher Sarchi

Chief Commercial Officer

Christopher Sarchi (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Replimune Group, Inc. (REPL). The largest single filing was $111K of REPL (12,000 sh × $9.24, as filed), executed Jun 1.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$111K
shares × price, as filed
Last traded
Jun 1
Filed Jun 3

Median ADV $90.1M across their filed names

Open performance→
Volume by month
$111K$55K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2026 · sells $111K
Buys $0 Sells $111K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
REPL Replimune Group, Inc. REPL · 0 buys · 1 sell 1 filing
Recent filings
REPLSALE Replimune Group, Inc. View filing → $111K
12,000 sh × $9.24
Exec Jun 1
Filed Jun 3 · 5:30 PM ET